• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Animal & Veterinary

  • Print
  • Share
  • E-mail

Additional Day Added To Meeting On Establishment Regulatory Thresholds On Antimicrobial Resistance

December 15, 2000

An additional day has been added to the Center for Veterinary Medicine (CVM) public meeting to discuss the establishment of regulatory thresholds on antimicrobial resistance. This meeting, originally titled "Establishment of Resistance and Monitoring Thresholds in Food-Producing Animals" and scheduled for October 10-11, 2000, was postponed until January 23-24, 2001. Most recently, the meeting has been expanded to include an additional day and has been re-titled, "Use of Antimicrobial Drugs in Food Animals and the Establishment of Regulatory Thresholds on Antimicrobial Resistance."

The new dates for the meeting are January 22 - 24, 2001. The meeting will be held from 8:30 a.m. to 5:00 p.m. at the DoubleTree Hotel, 1750 Rockville Pike, Rockville, MD, 20852.

Individuals who have already registered for the January meeting need not re-register. Individuals who have not registered may find the registration form and the agenda on the CVM Home Page.

For general inquiries about the meeting and registration, please contact Lynda W. Cowatch, CVM (HFV-100), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 301-827-5281. Technical inquiries should be directed to Aleta Sindelar, CVM (HFV-6), at 301-827-4515. When making reservations with the DoubleTree Hotel (1-800-222-8733), please refer to the "CVM Antimicrobial Resistance Public Meetings" to receive the group discount rate. Individuals who have already reserved rooms may wish to reserve additional day(s) at the hotel to include the earlier start date for the meeting. If you need special accommodations for a disability, please contact the DoubleTree Hotel at least 7 days in advance.

Written comments about the meeting should be submitted by March 24, 2001. Comments should be directed to Docket #98D-0969 and submitted to: Dockets Management Branch, (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Room 1061, Rockville, MD, 20852; or faxed to (301) 827-6870 with the appropriate identification number. Questions about your submission of comments may be directed to HFA-305 at (301) 827-6860.


Contact FDA

240-276-9115 FAX
Issued by: FDA, Center for Veterinary Medicine

Communications Staff, HFV-12

7519 Standish Place

Rockville, MD 20855